Quote

The biotech game is quickly changing. The people must demand their use of these treatments.

Biotech research is incredibly important for health-care innovation.

We're really going after truly creating sustainability of a disease-free state, creating a complete system for managing cancer patients for life, so that you can manage from onset of disease all the way through.

I'm an investor in a number of biotech companies, partly because of my incredible enthusiasm for the great innovations they will bring.

The potential for synthetic biology and biotechnology is vast; we all have an opportunity to create the future together.

Reducing the price of cancer drugs is a humanitarian move.

We're finally moving out of the realm of solely discussing biology in regards to a drug-based world.

My passion for innovation and my interest in the 'business of science' has seen Biocon commercialize many innovative platforms and products.

Throughout my career, as both a physician and a scientist, I have drawn inspiration from Merck's unwavering commitment to scientific excellence. Over time, this commitment has brought forth an unparalleled number of breakthrough medicines and vaccines that improve the lives of patients around the world.

Getting a traditional pharmaceutical to the market can cost a billion dollars or more. Newer, more tailored and targeted drugs called biologics are even more complex and expensive. Simple economics dictates that companies and venture funds will invest more in products that can generate a sufficient return.